The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Jul 30, 2024

- Jul 29, 2025

1.0

Claim your AMA PRA Category 1 Credit(s) credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiolog...

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Pati...

ATTRv-PN: Advances in Understanding and Managing Amyloid Disease with Peripheral Neuropath...